Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients.

Iwasaki M, Joki N, Tanaka Y, Ikeda N, Hayashi T, Kubo S, Asakawa T, Takahashi Y, Hirahata K, Imamura Y, Hase H.

Nephrology (Carlton). 2013 Jul;18(7):497-504. doi: 10.1111/nep.12063.

PMID:
23574011
2.

Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.

Helal I, Belhadj R, Mohseni A, Bazdeh L, Drissa H, Elyounsi F, Abdallah TB, Abdelmoula J, Kheder A.

Saudi J Kidney Dis Transpl. 2010 Mar;21(2):262-8.

3.

NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.

Reinhard H, Hansen PR, Wiinberg N, Kjær A, Petersen CL, Winther K, Parving HH, Rossing P, Jacobsen PK.

Cardiovasc Diabetol. 2012 Mar 5;11:19. doi: 10.1186/1475-2840-11-19.

4.

Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.

Schouten O, Hoeks SE, Goei D, Bax JJ, Verhagen HJ, Poldermans D.

J Vasc Surg. 2009 Feb;49(2):435-41; discussion 441-2. doi: 10.1016/j.jvs.2008.08.063. Epub 2008 Nov 22.

5.

NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.

Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.

Coron Artery Dis. 2008 Nov;19(7):481-7. doi: 10.1097/MCA.0b013e32830b4d0e.

PMID:
18923244
6.
7.

Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.

David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.

Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. Epub 2007 Dec 18.

8.

Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.

Shaikh K, Hanif B, Siddique AA, Shaikh MY, Khan MN.

J Coll Physicians Surg Pak. 2012 Dec;22(12):751-5. doi: 12.2012/JCPSP.751755.

PMID:
23217478
10.

Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.

Lee YJ, Song BG, Kim MS, Cho S, Chun WJ, Oh JH, Kim SR.

Clin Nephrol. 2013 Apr;79(4):253-60. doi: 10.5414/CN107684.

PMID:
23149248
11.

Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).

Mishra RK, Li Y, Ricardo AC, Yang W, Keane M, Cuevas M, Christenson R, deFilippi C, Chen J, He J, Kallem RR, Raj DS, Schelling JR, Wright J, Go AS, Shlipak MG; Chronic Renal Insufficiency Cohort Investigators.

Am J Cardiol. 2013 Feb 1;111(3):432-8. doi: 10.1016/j.amjcard.2012.10.019. Epub 2012 Nov 22.

PMID:
23178053
12.

Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.

Kremastinos DT, Hamodraka E, Parissis J, Tsiapras D, Dima K, Maisel A.

Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.

PMID:
20102869
13.

Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.

Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M.

J Cardiovasc Med (Hagerstown). 2009 Mar;10(3):238-44. doi: 10.2459/JCM.0b013e3283212ee0.

PMID:
19262210
14.
15.

Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.

Park JR, Choi JO, Han HJ, Chang SA, Park SJ, Lee SC, Choe YH, Park SW, Oh JK.

Int J Cardiovasc Imaging. 2012 Apr;28(4):763-72. doi: 10.1007/s10554-011-9876-4. Epub 2011 Apr 24.

PMID:
21516440
16.

Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.

Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE.

Nephrol Dial Transplant. 2009 Jun;24(6):1962-9. doi: 10.1093/ndt/gfp067. Epub 2009 Feb 23.

17.

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.

Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr.

J Am Coll Cardiol. 2006 Jan 17;47(2):345-53. Epub 2006 Jan 4.

18.

N-terminal pro-brain natriuretic peptide levels predict left ventricular systolic function in patients with chronic kidney disease.

Lee JE, Choi SY, Huh W, Park SW, Kim DJ, Oh HY, Kim YG.

J Korean Med Sci. 2009 Jan;24 Suppl:S63-8. doi: 10.3346/jkms.2009.24.S1.S63. Epub 2009 Jan 28.

19.

Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.

Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.

Clin Biochem. 2006 Jun;39(6):640-5. Epub 2006 Mar 3.

PMID:
16516185
20.

Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients.

Yamazaki M, Ogawa T, Tamei N, Ando Y, Nitta K.

Heart Vessels. 2011 Jul;26(4):421-7. doi: 10.1007/s00380-010-0066-4. Epub 2010 Dec 3.

PMID:
21127887
Items per page

Supplemental Content

Write to the Help Desk